LDCE.DE vs. ARQT

Last updated Jun 5, 2026

LDCE.DE (PIMCO Euro Low Duration Corporate Bond UCITS ETF Dist) is European Corporate Bonds fund tracking the PIMCO Low Duration Euro Corporate Bond, while ARQT (Arcutis Biotherapeutics, Inc.) is a stock. Over the past 5 years, LDCE.DE returned 1.27%/yr vs -2.71%/yr for ARQT. At a 0.06 correlation, their price movements are largely independent.

Performance

LDCE.DE vs. ARQT - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in PIMCO Euro Low Duration Corporate Bond UCITS ETF Dist (LDCE.DE) and Arcutis Biotherapeutics, Inc. (ARQT). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

LDCE.DE is traded in EUR, while ARQT is traded in USD. To make them comparable, the ARQT values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, LDCE.DE achieves a 0.33% return, which is significantly higher than ARQT's -23.55% return.

LDCE.DE

• 1D: 0.27%
• 1M: 0.57%
• YTD: 0.33%
• 6M: 0.13%
• 1Y: 2.14%
• 3Y*: 4.78%
• 5Y*: 1.27%
• 10Y*: 1.27%

ARQT

• 1D: 2.67%
• 1M: -8.14%
• YTD: -23.55%
• 6M: -29.48%
• 1Y: 60.09%
• 3Y*: 33.23%
• 5Y*: -2.71%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LDCE.DE vs. ARQT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
LDCE.DE PIMCO Euro Low Duration Corporate Bond UCITS ETF Dist	0.33%	4.19%	4.68%	6.54%	-8.43%	0.32%	0.63%
ARQT Arcutis Biotherapeutics, Inc.	-23.55%	83.73%	359.74%	-78.83%	-24.22%	-20.76%	17.17%

Correlation

The correlation between LDCE.DE and ARQT is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.13
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (5Y) Calculated over the trailing 5-year period	0.06
Correlation (All Time) Calculated using the full available price history since Feb 3, 2020	0.06

Return for Risk

LDCE.DE vs. ARQT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LDCE.DE

LDCE.DE Risk / Return Rank: 20
LDCE.DE Sharpe Ratio Rank: 20
LDCE.DE Sortino Ratio Rank: 19
LDCE.DE Omega Ratio Rank: 20
LDCE.DE Calmar Ratio Rank: 19
LDCE.DE Martin Ratio Rank: 22

ARQT

ARQT Risk / Return Rank: 73
ARQT Sharpe Ratio Rank: 75
ARQT Sortino Ratio Rank: 74
ARQT Omega Ratio Rank: 71
ARQT Calmar Ratio Rank: 72
ARQT Martin Ratio Rank: 72

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LDCE.DE vs. ARQT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for PIMCO Euro Low Duration Corporate Bond UCITS ETF Dist (LDCE.DE) and Arcutis Biotherapeutics, Inc. (ARQT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LDCE.DE	ARQT	Difference
Sharpe ratio: Return per unit of total volatility	0.67	1.11	-0.44
Sortino ratio: Return per unit of downside risk	0.98	1.91	-0.94
Omega ratio: Gain probability vs. loss probability	1.13	1.23	-0.11
Calmar ratio: Return relative to maximum drawdown	0.81	1.69	-0.88
Martin ratio: Return relative to average drawdown	2.69	3.93	-1.24
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LDCE.DE vs. ARQT - Sharpe Ratio Comparison

The current LDCE.DE Sharpe Ratio is 0.67, which is lower than the ARQT Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of LDCE.DE and ARQT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LDCE.DE	ARQT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.67	1.11	-0.44
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.44	-0.04	+0.48
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.51	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.60	-0.01	+0.61

Drawdowns

LDCE.DE vs. ARQT - Drawdown Comparison

The maximum LDCE.DE drawdown since its inception was -11.07%, smaller than the maximum ARQT drawdown of -95.09%. Use the drawdown chart below to compare losses from any high point for LDCE.DE and ARQT.

Drawdown Indicators

	LDCE.DE	ARQT	Difference
Max Drawdown Largest peak-to-trough decline	-11.07%	-95.09%	+84.02%
Max Drawdown (1Y) Largest decline over 1 year	-2.63%	-37.32%	+34.69%
Max Drawdown (3Y) Largest decline over 3 years	-2.63%	-83.32%	+80.69%
Max Drawdown (5Y) Largest decline over 5 years	-11.07%	-93.74%	+82.67%
Max Drawdown (10Y) Largest decline over 10 years	-11.07%	—	—
Current Drawdown Current decline from peak	-0.77%	-45.07%	+44.30%
Average Drawdown Average peak-to-trough decline	-1.75%	-52.36%	+50.61%
Ulcer Index Depth and duration of drawdowns from previous peaks	0.79%	15.97%	-15.18%

Volatility

LDCE.DE vs. ARQT - Volatility Comparison

The current volatility for PIMCO Euro Low Duration Corporate Bond UCITS ETF Dist (LDCE.DE) is 1.19%, while Arcutis Biotherapeutics, Inc. (ARQT) has a volatility of 20.10%. This indicates that LDCE.DE experiences smaller price fluctuations and is considered to be less risky than ARQT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LDCE.DE	ARQT	Difference
Volatility (1M) Calculated over the trailing 1-month period	1.19%	20.10%	-18.91%
Volatility (6M) Calculated over the trailing 6-month period	2.71%	35.64%	-32.93%
Volatility (1Y) Calculated over the trailing 1-year period	3.18%	56.91%	-53.73%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	2.88%	70.84%	-67.96%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	2.45%	76.53%	-74.08%

Dividends

LDCE.DE vs. ARQT - Dividend Comparison

LDCE.DE's dividend yield for the trailing twelve months is around 3.37%, while ARQT has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
ARQT Arcutis Biotherapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LDCE.DE PIMCO Euro Low Duration Corporate Bond UCITS ETF Dist	3.37%	3.22%	2.73%	1.72%	0.94%	0.51%	0.51%	0.63%	0.65%	0.71%	0.95%	0.93%

Frequently Asked Questions

Can I hold both LDCE.DE and ARQT in my portfolio?

LDCE.DE and ARQT have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.